ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Poor adherence to asthma controller medication may link to poor asthma outcome. A metered
dose device with built-in dose counter helps physicians to monitor drug compliance in asthma
patients. Mobile-phone based self management opens a window for better asthma control. The
present study aims to investigate the relationship between the adherence to controller
medication of combined inhaled corticosteroid/long acting beta2-agonists, assessing by
integrated dose counter, and the level of airway inflammation and asthma control. Moreover,
the investigators also use a new asthma self-management Apps to enhance drug compliance. With
the application of the new, easily available tools, the investigator expect to increase
adherence rates, and hence, to reduce airway inflammation and improve the level of asthma
control.
Phase:
N/A
Details
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate